[go: up one dir, main page]

MX2017011648A - Metodos de piolisina y composiciones. - Google Patents

Metodos de piolisina y composiciones.

Info

Publication number
MX2017011648A
MX2017011648A MX2017011648A MX2017011648A MX2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A
Authority
MX
Mexico
Prior art keywords
methods
piolisine
compositions
pyogenes
improved
Prior art date
Application number
MX2017011648A
Other languages
English (en)
Other versions
MX380387B (es
Inventor
Moutafis George
Poppe Allen
Herberg John
Andrew MOONEN Glenn
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2017011648A publication Critical patent/MX2017011648A/es
Publication of MX380387B publication Critical patent/MX380387B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

En la presente, se describen métodos para medios de cultivo y condiciones de cultivo mejorados para Trueperella pyogenes, también se describen métodos mejorados para el aislamiento y la purificación de piolisina de Truepereila pyogenes.
MX2017011648A 2015-03-12 2016-03-14 Metodos de piolisina y composiciones. MX380387B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562132050P 2015-03-12 2015-03-12
PCT/US2016/022297 WO2016145432A1 (en) 2015-03-12 2016-03-14 Pyolysin methods and compositions

Publications (2)

Publication Number Publication Date
MX2017011648A true MX2017011648A (es) 2017-11-02
MX380387B MX380387B (es) 2025-03-12

Family

ID=55640899

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011648A MX380387B (es) 2015-03-12 2016-03-14 Metodos de piolisina y composiciones.

Country Status (12)

Country Link
US (1) US10858401B2 (es)
EP (1) EP3268380B1 (es)
JP (1) JP6570648B2 (es)
KR (1) KR101999043B1 (es)
CN (1) CN107466326B (es)
AU (1) AU2016228514B2 (es)
BR (1) BR112017019460B1 (es)
CA (1) CA2979541C (es)
DK (1) DK3268380T3 (es)
ES (1) ES2711893T3 (es)
MX (1) MX380387B (es)
WO (1) WO2016145432A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107101933A (zh) * 2017-07-10 2017-08-29 郑州金域临床检验中心(普通合伙) 一种血液分析组合物及其应用
CN116814486B (zh) * 2023-06-26 2024-11-19 青岛农业大学 一种促进化脓隐秘杆菌生长的细菌培养基

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US5210037A (en) * 1988-03-22 1993-05-11 Centocor Incorporated Method to enhance TPA production
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
ATE506074T1 (de) * 1995-06-07 2011-05-15 Univ Kansas State Actinomyces pyogenes und actinomyces pyogenes/fusobakterium necrophorum impfstoffe zur immunisierung von vieh und schafen
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
WO2007144647A2 (en) * 2006-06-15 2007-12-21 Timothy John Mitchell Adjuvant compositions
LT5705B (en) * 2009-02-23 2011-01-25 Uab Profarma Monoclonal antibodies against vaginolysin
AU2013353403B2 (en) 2012-11-29 2018-04-19 Cornell University Vaccine for intrauterine disease
CN104073450A (zh) * 2014-02-28 2014-10-01 重庆市畜牧科学院 山羊源化脓隐秘杆菌及其应用
CN103937889B (zh) * 2014-04-14 2015-09-30 陕西省动物研究所 一种化脓隐秘杆菌lamp检测用引物及检测方法

Also Published As

Publication number Publication date
JP6570648B2 (ja) 2019-09-04
WO2016145432A1 (en) 2016-09-15
EP3268380B1 (en) 2018-12-26
NZ734998A (en) 2024-01-26
CN107466326B (zh) 2021-10-15
AU2016228514A1 (en) 2017-09-14
MX380387B (es) 2025-03-12
CA2979541C (en) 2019-07-16
CA2979541A1 (en) 2016-09-15
US20180057543A1 (en) 2018-03-01
JP2018507704A (ja) 2018-03-22
ES2711893T3 (es) 2019-05-08
DK3268380T3 (en) 2019-02-18
BR112017019460B1 (pt) 2023-11-21
CN107466326A (zh) 2017-12-12
KR101999043B1 (ko) 2019-07-10
BR112017019460A2 (pt) 2018-05-15
AU2016228514B2 (en) 2021-06-17
KR20170126492A (ko) 2017-11-17
US10858401B2 (en) 2020-12-08
EP3268380A1 (en) 2018-01-17

Similar Documents

Publication Publication Date Title
MX2022009148A (es) Composiciones y metodos para el tratamiento de hemoglobinopatias.
MX2015013202A (es) Cultivo, produccion, procesamiento y uso de cannabis de especialidad.
MX2018006767A (es) Composiciones y metodos para oncologia inmunologica.
UY35510A (es) ?composiciones y métodos para mejorar la estabilidad microbiana?.
AR101845A1 (es) Anticuerpos anti-her2 e inmunoconjugados
MX388301B (es) Il-23a y tnf-alfa orientados y compuesto y sus usos.
MX384024B (es) Peptidos macrociclicos utiles como inmunomoduladores.
AR101905A1 (es) Compuestos bicíclicos
DK3220741T3 (da) Sammensætning og kits til hæmning af patogen mikrobiel infektion og fremgangsmåder til anvendelse af samme
MX2016000997A (es) Metodos y composiciones para detectar contaminacion bacteriana.
FR3024465B1 (fr) Caracterisation de micro-organismes par maldi-tof
CL2015003479A1 (es) Métodos y composiciones de fermentación bacterial.
EP3448982A4 (en) CELL CULTURE MEDIUM
EP3682009A4 (en) GENE EXPRESSION SYSTEM FOR PROBIOTIC MICROORGANISMS
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
HUE063210T2 (hu) Mikroorganizmusok eltartása
BR112018009097A8 (pt) spodoptera frugiperda resistente a vip3a
MX2016013240A (es) Rutas semi-sinteticas para compuestos organicos.
MX382864B (es) Formulaciones de anticuerpos cristalinos.
CO2017010143A2 (es) Procesos para preparar fluorocetólidos
DK3436568T3 (da) Kulturmedium til pluripotente stamceller
IT201700026465A1 (it) Supplementi per colture cellulari
MX2017011648A (es) Metodos de piolisina y composiciones.
IL249410B (en) Culture medium for cellular immunotherapy
EP3562928C0 (en) RESUMPTION AFTER FAILURE IN CELL CULTURE BIOREACTORS